UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2514) 2514
humans (2358) 2358
life sciences & biomedicine (2175) 2175
virology (1544) 1544
hiv-1 - genetics (1385) 1385
animals (1198) 1198
aids/hiv (1077) 1077
viruses (1012) 1012
molecular sequence data (985) 985
hiv (890) 890
gene products, env - genetics (872) 872
immunology (824) 824
hiv-1 - immunology (813) 813
env gene products, human immunodeficiency virus - genetics (744) 744
virus diseases (726) 726
hiv infections - virology (723) 723
infectious diseases (702) 702
amino acid sequence (664) 664
female (655) 655
cell line (534) 534
env gene products, human immunodeficiency virus - immunology (511) 511
gene products, env - immunology (500) 500
male (492) 492
human immunodeficiency virus--hiv (460) 460
phylogeny (458) 458
hiv infections - immunology (455) 455
research (442) 442
base sequence (438) 438
aids vaccines - immunology (428) 428
research article (421) 421
hiv-1 - physiology (403) 403
hiv-1 - classification (375) 375
mice (375) 375
gene products, env - metabolism (371) 371
genes, env (362) 362
vaccines (351) 351
hiv antibodies - immunology (346) 346
hiv-1 (343) 343
human immunodeficiency virus (338) 338
adult (336) 336
science & technology - other topics (335) 335
multidisciplinary sciences (334) 334
microbiology (330) 330
proteins (322) 322
mutation (319) 319
hiv-1 - isolation & purification (307) 307
health aspects (296) 296
genetic variation (295) 295
antibodies (294) 294
sequence analysis, dna (294) 294
hiv-1 - metabolism (293) 293
aids (283) 283
neutralization tests (273) 273
env gene products, human immunodeficiency virus - metabolism (260) 260
analysis (257) 257
antibodies, neutralizing - immunology (257) 257
virus replication (257) 257
infections (255) 255
biochemistry & molecular biology (253) 253
hiv infection (252) 252
hiv envelope protein gp120 - genetics (245) 245
aids vaccines (242) 242
acquired immune deficiency syndrome--aids (229) 229
polymerase chain reaction (229) 229
simian immunodeficiency virus - genetics (226) 226
glycoproteins (223) 223
macaca mulatta (222) 222
genetic aspects (220) 220
vaccination (209) 209
immunization (208) 208
gene products, env - chemistry (207) 207
hela cells (204) 204
hiv antibodies - blood (203) 203
hiv infections - prevention & control (195) 195
hiv-1 - pathogenicity (194) 194
gene products, gag - genetics (192) 192
gene expression (190) 190
medicine (189) 189
physiological aspects (189) 189
cells, cultured (188) 188
env gene products, human immunodeficiency virus - chemistry (188) 188
genetic vectors (184) 184
middle aged (184) 184
genotype (183) 183
binding sites (182) 182
rna, viral - genetics (181) 181
science (180) 180
env gene products, human immunodeficiency virus (176) 176
simian immunodeficiency virus - immunology (175) 175
hiv envelope protein gp120 - immunology (171) 171
biology (168) 168
acquired immune deficiency syndrome (163) 163
antigens (163) 163
cd4 antigens - metabolism (163) 163
transfection (162) 162
hiv infections - epidemiology (161) 161
aids vaccines - genetics (159) 159
immune response (159) 159
cell biology (157) 157
mice, inbred balb c (157) 157
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 04/2018, Volume 13, Issue 4, pp. e0196548 - e0196548
Background Yunnan has the greatest share of reported human immunodeficiency virus (HIV... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | env Gene Products, Human Immunodeficiency Virus - classification | Humans | Middle Aged | Male | Young Adult | env Gene Products, Human Immunodeficiency Virus - genetics | Homosexuality, Male | HIV-1 - isolation & purification | China | HIV Infections - diagnosis | Adult | HIV Infections - transmission | RNA, Viral - metabolism | gag Gene Products, Human Immunodeficiency Virus - genetics | pol Gene Products, Human Immunodeficiency Virus - genetics | HIV Infections - virology | Probability | Genotype | HIV-1 - genetics | Sequence Analysis, DNA | pol Gene Products, Human Immunodeficiency Virus - classification | gag Gene Products, Human Immunodeficiency Virus - classification | Drug Resistance, Viral - genetics | RNA, Viral - chemistry | Adolescent | Aged | Monte Carlo Method | Disease transmission | Genetic aspects | Research | HIV infection | MSM (Men who have sex with men) | Risk factors | Diseases | Epidemics | Networks | Sexually transmitted diseases--STD | Sex | Markov chains | Viruses | Infections | Genomes | Genetic distance | Phylogeny | Drug resistance | Epidemiology | Gene sequencing | Gag protein | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Genetic analysis | Phylogenetics | Clusters | Population | Bioinformatics | Genotypes | Monte Carlo method | Disease control | Antiretroviral therapy | Disease prevention | Men | Mutation | Bayesian analysis | Index Medicus | STD | Sexually transmitted diseases | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 11/2018, Volume 13, Issue 11, pp. e0205139 - e0205139
Background Live, attenuated viral vectors that express HIV-1 antigens are being investigated as an approach to generating durable immune responses against HIV-1 in humans... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antigens, Viral - therapeutic use | HIV-1 - pathogenicity | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Middle Aged | AIDS Vaccines - immunology | Acquired Immunodeficiency Syndrome - therapy | Antigens, Viral - genetics | Male | AIDS Vaccines - therapeutic use | Genetic Vectors - therapeutic use | env Gene Products, Human Immunodeficiency Virus - therapeutic use | Acquired Immunodeficiency Syndrome - genetics | Young Adult | Acquired Immunodeficiency Syndrome - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | Adenoviridae - genetics | Adult | Female | Acquired Immunodeficiency Syndrome - virology | Virus Replication - drug effects | Immunity, Cellular - genetics | Virus Replication - immunology | HIV-1 - genetics | Antigens, Viral - immunology | Immunity, Cellular - immunology | HIV-1 - immunology | AIDS Vaccines - genetics | Prevention | AIDS vaccines | Usage | Safety and security measures | Analysis | Clinical trials | Research | HIV infection | Shedding | Mucosa | Vaccination | Viruses | Vaccines | Replicating | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Attenuation | Drug dosages | Enzyme-linked immunosorbent assay | Expression vectors | Antigens | Dentistry | Health care facilities | Secretions | Typhoid | Monkeys & apes | Immune response (humoral) | Virology | Medicine | Infectious diseases | Disease transmission | Immunogenicity | Adenoviruses | Rectum | Adults | Index Medicus | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal of Virology, ISSN 0022-538X, 02/2012, Volume 86, Issue 4, pp. 2239 - 2250
OA  Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+... 
Life Sciences & Biomedicine | Science & Technology | Virology | HIV Infections - prevention & control | Gene Products, env - immunology | Gene Products, env - administration & dosage | Humans | AIDS Vaccines - immunology | Male | Gene Products, nef - genetics | HIV - immunology | Macaca mulatta | HIV Infections - immunology | Simian Acquired Immunodeficiency Syndrome - virology | Simian Immunodeficiency Virus - genetics | Gene Products, env - genetics | Disease Models, Animal | Gene Products, nef - administration & dosage | Simian Immunodeficiency Virus - immunology | Gene Products, gag - immunology | Immunization | Gene Products, gag - genetics | SAIDS Vaccines - administration & dosage | HIV Infections - virology | Defective Viruses - genetics | Adenoviruses, Human - physiology | Genetic Vectors - metabolism | HIV-1 - genetics | Genetic Vectors - genetics | Simian Acquired Immunodeficiency Syndrome - prevention & control | Defective Viruses - physiology | SAIDS Vaccines - genetics | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | AIDS Vaccines - genetics | Antibodies, Viral - immunology | HIV - genetics | Adenoviruses, Human - genetics | Gene Products, gag - administration & dosage | AIDS Vaccines - administration & dosage | Gene Products, nef - immunology | Index Medicus | Pathogenesis and Immunity
Journal Article
PloS one, ISSN 1932-6203, 05/2019, Volume 14, Issue 5, pp. e0216949 - e0216949
.... Since the Ebola virus envelope glycoprotein (EboGP) has strong DC-targeting ability, we investigated whether EboGP is able to direct HIV particles towards DCs efficiently and promote potent HIV-specific immune responses... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Immunogenicity, Vaccine | HIV Infections - prevention & control | Spleen - immunology | Dendritic Cells - immunology | Humans | AIDS Vaccines - immunology | Spleen - drug effects | HIV Infections - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | HIV-1 - growth & development | Chemokine CCL3 - genetics | HIV Antibodies - biosynthesis | gag Gene Products, Human Immunodeficiency Virus - genetics | Gene Expression | Immunization | Viral Envelope Proteins - genetics | HIV Infections - virology | Lymphocytes - cytology | Spleen - cytology | Ebolavirus - chemistry | Interleukin-4 - immunology | Vaccines, Virus-Like Particle - immunology | Mice | AIDS Vaccines - administration & dosage | gag Gene Products, Human Immunodeficiency Virus - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | Chemokine CCL3 - immunology | Molecular Targeted Therapy | Vaccines, Virus-Like Particle - genetics | Immunity, Cellular - drug effects | Lymphocytes - immunology | Macrophages - virology | HEK293 Cells | Dendritic Cells - drug effects | Female | Interleukin-4 - genetics | Dendritic Cells - virology | Macrophages - immunology | HIV-1 - drug effects | Mice, Inbred C57BL | HIV-1 - immunology | Vaccines, Virus-Like Particle - administration & dosage | Animals | Lymphocytes - drug effects | Immunity, Humoral - drug effects | AIDS Vaccines - genetics | Macrophages - drug effects | Viral Envelope Proteins - immunology | Primary Cell Culture | AIDS vaccines | Usage | Immune response | Dendritic cells | Analysis | Product development | Glycoproteins | Health aspects | Health sciences | Peptides | Laboratories | Viruses | Infections | Vaccines | Macrophages | Immunity | Virus-like particles | Ebola virus | Interleukin 4 | Replicating | Immunology | Gag protein | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Splenocytes | Human immunodeficiency virus--HIV | Immunity (humoral) | Public health | Immune system | Antigens | Cytokines | Inflammation | Immune response (humoral) | Virology | Zoonoses | Medicine | Monocytes | Infectious diseases | Mucin | Immunogenicity | Human performance | Dendritic structure | Index Medicus | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal of virology, ISSN 0022-538X, 2015, Volume 89, Issue 20, pp. 10648 - 10655
Journal Article
Journal Article